Skip to main content

Table 3 Risk factors predicting non- Candida fungaemia

From: Clinical characteristics and risk factors of non-Candida fungaemia

Variables

Univariate analysis

Multivariate analysis

 

Crude OR (95% CI)

Pvalue

Adjusted OR (95% CI)

Pvalue

Co-morbidities

  Solid malignancy

0.55 (0.46-0.65)

< 0.01

-

-

  Chronic kidney disease

5.40 (1.48-19.7)

0.01

-

-

  Collagen disease

3.75 (0.84-16.7)

0.09

9.00 (1.58-51.4)

0.01

Underlying conditions

  Prior bacteraemia

3.66 (1.00-13.4)

0.04

  

  Colonisation by causative yeasts

3.77 (0.94-15.1)

0.05

-

-

  Renal replacement therapy

8.33 (2.12-32.8)

< 0.01

15.0 (3.06-73.4)

< 0.01

Corticosteroid therapy

3.84 (1.05-14.1)

0.04

-

-

  Chemotherapy

0.73 (0.65-0.82)

0.04

-

-

  Other immunosuppressant therapy

4.27 (0.94-19.3)

0.08

  

SOFA score a

1.13 (1.03-1.26)

0.02

-

-

  1. OR: odds ratio; SOFA: sequential organ failure assessment.
  2. P values are marked in bold if < 0.05.
  3. a Variables categorised as an ordinal scale in 1-point increments: OR > 1 is the increase in likelihood of the outcome with a 1-point increase in the factor.
  4. P < 0.10, variable was included in the multivariate analysis of outcomes from non-Candida fungaemia versus candidaemia.